New Mouth-Dissolving pastilles tested in fight against aggressive brain cancer
Disease control
Recruiting now
This study is testing whether adding a new experimental medicine called APG-157, taken as dissolving pastilles in the mouth, can help control aggressive brain tumors (high-grade glioma) that have returned after previous treatment. The APG-157 pastilles are given alongside the sta…
Phase: PHASE1, PHASE2 • Sponsor: Aveta Biomics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC